Exercise Fatiguability in Older Adults: The Protective Effects of Dietary Nitrate Supplementation
1 other identifier
interventional
40
1 country
1
Brief Summary
Vascular and skeletal muscle function decline with age and are associated with decreased nitric oxide (NO) bioavailability. Dietary nitrate supplementation in the form of beet root juice increases NO bioavailability and improves exercise tolerance in younger adults, yet its effects on fatigability in older adults are largely unknown. The proposed research will investigate the impact of increased NO bioavailability on vascular function, skeletal muscle bioenergetics, and fatigability in older (≥65 yrs) men and women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2022
CompletedFirst Posted
Study publicly available on registry
April 6, 2022
CompletedStudy Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedAugust 24, 2022
August 1, 2022
1.7 years
February 14, 2022
August 22, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change in fatigability of the knee extensor muscles with beetroot juice supplementation
Fatigability will be quantified as the reduction in limb muscle power output during a 4-minute dynamic fatiguing exercise task using a dynamometer. Fatigability after 7 days of beetroot juice supplementation will be compared with fatigability after 7 days of placebo supplementation, with the outcome measure being the change (or difference) between these two supplementation conditions.
Day 8 (after 7 days of placebo supplementation) and day 29 (after 14 days of a washout period with no supplementation plus 7 days of beetroot juice supplementation)
Secondary Outcomes (2)
Change in femoral artery blood flow with beetroot juice supplementation
Day 8 (after 7 days of placebo supplementation) and day 29 (after 14 days of a washout period with no supplementation plus 7 days of beetroot juice supplementation)
Change in muscle efficiency with beetroot juice supplementation
Day 8 (after 7 days of placebo supplementation) and day 29 (after 14 days of a washout period with no supplementation plus 7 days of beetroot juice supplementation)
Other Outcomes (2)
Change in plasma nitrate concentration with beetroot juice supplementation
Day 8 (after 7 days of placebo supplementation) and day 29 (after 14 days of a washout period with no supplementation plus 7 days of beetroot juice supplementation)
Change in plasma nitrite concentration with beetroot juice supplementation
Day 8 (after 7 days of placebo supplementation) and day 29 (after 14 days of a washout period with no supplementation plus 7 days of beetroot juice supplementation)
Study Arms (2)
Beetroot Juice
ACTIVE COMPARATORThe subject will ingest 140mL of a nitrate-rich beetroot juice each day for 7 consecutive days.
Placebo Beetroot Juice
PLACEBO COMPARATORThe subject will ingest 140mL of a placebo (nitrate-depleted) beetroot juice each day for 7 consecutive days.
Interventions
7 days of 140 mL per day of beetroot juice
Eligibility Criteria
You may qualify if:
- Healthy men and women ≥ 60 years old
You may not qualify if:
- body mass index ≥40 kg/m2;
- type 1 or type 2 diabetes or HbA1c \>6.5%
- uncontrolled hypertension;
- active cancer, cancer in remission, or having received treatment for any form of cancer in the previous five years;
- coronary artery disease;
- cardiovascular disease (e.g., PAD, PVD);
- abnormal and untreated thyroid function;
- chronic and/or regular nonsteroidal anti-inflammatory drugs (NSAID) consumption,
- tobacco use (includes smoking);
- any condition that presents a limitation to exercise (e.g., severe arthritis, COPD, neuromuscular disorder, moderate or severe cognitive impairment, Alzheimer's Disease, severe untreated sleep apnea).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marquette University
Milwaukee, Wisconsin, 53233, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 14, 2022
First Posted
April 6, 2022
Study Start
May 1, 2022
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
August 24, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share